Les meilleurs podcasts Lung Cancer (2024)

1
Témoignage d’une patiente : Julie Desjardins 25:29

3d ago25:29

25:29

La Dre Nathalie Daaboul s’entretient avec Julie Desjardins de la vallée d'Annapolis, en Nouvelle-Écosse, dans notre premier épisode du balado en français Voix du cancer du poumon. Julie lutte contre un cancer du poumon ALK+ de stade IV depuis qu’elle a reçu un diagnostic inattendu en juillet 2022, alors qu’elle n’avait que 39 ans. Elle fait part de…

1
The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences 1:00:11

3d ago1:00:11

1:00:11

Dr Suresh S Ramalingam from the Emory University School of Medicine in Atlanta, Georgia and Dr Gregory J Riely from Memorial Sloan Kettering Cancer Center in New York, New York discuss the implications of recent data sets for the current and future management of lung cancer.Par Neil Love, MD

1
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer 1:05:42

13d ago1:05:42

1:05:42

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with lung cancer.Par Neil Love, MD

1
Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences 54:39

21d ago54:39

54:39

Dr Stephen V Liu from Georgetown University Hospital in Washington, DC, reviews recently presented data with and newly approved therapies for localized and advanced lung cancers.Par Neil Love, MD

1
Ep 87. Self-Advocacy Without Anger: Sonia’s Lung Cancer Story 35:12

22d ago35:12

35:12

In this episode, Dr. Paul Wheatley-Price chats with Sonia Turingia who was diagnosed with Stage 4 lung cancer in Spring 2023. Sonia shares her journey being diagnosed with cancer, navigating the challenges during treatment, why she believes it's important to self-advocate, and how to do that without anger.…

1
The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review 42:46

1M ago42:46

42:46

Dr Jacob Sands from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent presentations on approved and investigational therapies in small cell lung cancer from the 2024 World Conference on Lung Cancer.Par Neil Love, MD

1
The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer 1:00:07

1M ago1:00:07

1:00:07

Dr Edward Garon from UCLA Health Jonsson Comprehensive Cancer Center and Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid share their perspectives on recent datasets from the 2024 World Conference on Lung Cancer on the management of non-small cell lung cancer without actionable genomic alterations.…

1
Ep 86. Best of 2024 WCLC & ESMO 37:44

1M ago37:44

37:44

In this episode, Dr. Paul Wheatley-Price chats with Dr. Peter Ellis, Thoracic Medical Oncologist at the Juravinski Cancer Center and Professor at McMaster University about the highlights at this year's annual World Conference of Lung Cancer (WCLC) in San Diego and European Society of Medical Oncology (ESMO) Conference in Barcelona. Some very exciti…

1
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR 58:13

2M ago58:13

58:13

Dr Ibiayi Dagogo-Jack from Massachusetts General Hospital in Boston and Dr Corey J Langer from the Abramson Cancer Center in Philadelphia, Pennsylvania, discuss the implications of recent datasets for the current and future management of non-small cell lung cancer with actionable targets beyond EGFR.…

1
Ep 83. The History Of Lung Cancer in Canada 30:19

2M ago30:19

30:19

In this episode, Dr. Paul Wheatley-Price chats with Dr. Stephanie Mercier, Medical Oncology Resident at the University of Ottawa & Dr. Stephen Lam, Respirologist and Lead of the BC Screening Program at the University of British Columbia. They talk about the recent paper they published together highlighting the significant Canadian contributions to …

1
Ep 85. ALK-Positive Lung Cancer: The 2024 Update 34:39

2M ago34:39

34:39

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Geoffrey Liu, Medical Oncologist at Princess Margaret Cancer Center and a Canadian leader in opening dozens of clinical trials. Dr. Liu gives a rundown of everything you need to know about ALK-positive lung cancer - what is ALK, how common is it, how this type of lung cancer is treated, an…

1
Ep 80. Research in Canada: Equity in Clinical Trials 30:31

2M ago30:31

30:31

In this episode, Dr. Paul Wheatley-Price sits down with guests Dr. Lacey Pitre, Medical Oncolgist & Dr. Stacey Santi, Medical Research Chair at Health Sciences North in Sudbury, Ontario. Drs. Pitre and Santi are one of the recipients of a $100,000 research grant offered jointly by Pfizer Canada, Lung Cancer Canada, Lung Health Foundation, and Assoc…

1
Ep 82. The Role of Nursing in Cancer Care 23:18

2M ago23:18

23:18

In this episode, Dr. Paul Wheatley-Price sits down with Shannon Farley, a Nurse Practitioner (NP) at the William Osler Health System in Brampton, ON. They chat about what an NP is and the difference with other types of nurses, current challenges in the ERs and how nurses play a role in "diverging" cancer patients away from the emergency room, and t…

1
Ep 84. All About Common Sense Oncology 33:09

2M ago33:09

33:09

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Christopher Booth, Medical Oncologist and Health Services Researcher at Queen’s University, to talk about Common Sense Oncology. CSO is an initiative Started by Dr. Booth amongst Canadian and global partners to ensure that patients have access to cancer treatments that provide meaningful i…

1
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations 58:19

2M ago58:19

58:19

Dr Joshua K Sabari from the NYU Langone Health Perlmutter Cancer Center and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for non-small cell lung cancer with EGFR mutations.Par Neil Love, MD

1
Caregiving for Your Loved One with Cancer 51:52

2M ago51:52

51:52

- Definition of a Caregiver- What Research Tells Us About Caregivers’ Well Being- Caregiving for an Older Adult- Caregiving for a Younger Adult- Caregiving for a Friend- Caregivers for Cancer Survivors- Couples, Partners, Siblings & Friends- Family, Partner & Friend Communication- Care Coordination: Challenges & Tips- Stresses on Family, Partners &…

1
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors 59:19

2M ago59:19

59:19

Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.Par Neil Love, MD

1
Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation 2:03:22

3M ago2:03:22

2:03:22

Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts, Prof Tom John from the Peter MacCallum Cancer Centre in Melbourne, Australia, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, Massachusetts, and Dr Alexander Spira from the Virginia Cancer Specialists Research Program in Fairfax, discuss recent updates …

1
Current Perspectives on Cancer Survivorship 55:47

3M ago55:47

55:47

- Overview of Cancer Survivorship- Managing Post Treatment Side Effects/Late Effects- Quality-of-Life Concerns- Fear of Recurrence- Finding Your New Normal- The Importance of Treatment Summaries and Encounter Notes- Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns- Guidelines to Prepare f…

1
Insights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLC

3M ago

—

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joshua E. Reuss, MD The phase 2 ICARUS-Lung01 study evaluated not only the efficacy and safety of datopotomab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC), but also potential biomarkers associated with response and/or resistance. Here to discuss…

1
Poster Pearl: Dato-DXd Demonstrates Intracranial Efficacy in NSCLC

3M ago

—

Host: Jacob Sands, MD Guest: Aaron Lisberg, MD Brain metastases are a frequent complication of lung cancer, which is why the TROPION-Lung05 trial evaluated the intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced metastatic non-small cell lung cancer (NSCLC). According to the data, Dato-DXd demonst…

1
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer 1:01:23

3M ago1:01:23

1:01:23

Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting.Par Neil Love, MD

1
Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer 1:01:43

4M ago1:01:43

1:01:43

Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment…

1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer 1:00:53

4M ago1:00:53

1:00:53

Dr Matthew Gubens from the University of California, San Francisco summarizes important 2023 datasets guiding the use of immunotherapy and other nontargeted approaches for patients with NSCLC and no actionable mutations.Par Neil Love, MD

1
Ep 81. Best Of ASCO 2024 37:21

4M ago37:21

37:21

In this episode, Dr. Paul Wheatley-Price and Dr. Rosalyn Juergens, Medical Oncologist at the Juravinski Cancer Center and Co-Chair of LCC's Medical Advisory Committee, discuss the top highlights in lung cancer research presented at the 2024 ASCO Annual Conference held in Chicago this past June.Par Lung Cancer Canada

1
Oncology Today with Dr Neil Love: An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation 47:34

4M ago47:34

47:34

Dr Jonathan W Goldman from UCLA Health in Santa Monica, California summarizes recent developments presented at ASCO 2024 for patients with non-small cell lung cancer with an EGFR mutation.Par Neil Love, MD

1
Ep 79. Joys & Challenges Of Lung Cancer Care In Rural Communities 40:53

5M ago40:53

40:53

In this episode, Dr. Paul Wheatley-Price chats with Dr. Michela Febbraro and Dr. Silvana Spadafora, Medical Oncologists at the Algoma District Cancer Centre in Sault Ste. Marie, ON and also, mother-and daughter-duo. They talk about the joys, challenges, and everything in between of living and caring for patients with lung cancer in rural and remote…

1
Current Perspectives on the Future of Cancer Research 1:13:03

5M ago1:13:03

1:13:03

- Understanding the Future of Cancer Research & Clinical Trials- Increased Focus on Earlier Detection & Treatment of Cancer- Health Care Disparities Research- Enhanced Knowledge of the Molecular Portrait of Cancer- Artificial Intelligence (AI) Driven Approaches for Diagnosis & Treatment of Cancer- Microsatellite Instability (MSI): Mutations in DNA …

1
Non-Small Cell Lung Cancer: For Caregivers 53:17

5M ago53:17

53:17

- Overview of Non-Small Cell Lung Cancer- The Important Role of the Caregiver in Communicating with the Health Care Team- Taking on the Role of the Caregiver- What Research Tells Us About Caregivers- The Caregiver’s Role in Decision Making for a Loved One with Non-Small Cell Lung Cancer- Challenges in Communicating with the Health Care Team- Challe…

1
How Health Care Disparities May Influence Your Cancer Treatment 59:22

5M ago59:22

59:22

- Disproportionate Burden of COVID & Cancer on People of Color- Social Determinants of Health, Including Languages Spoken & Health Literacy- Influence of the Local & Regional Environment in Which You Live on Your Access to Oncology Care- Effect of COVID on Health Care Systems- How Race May Impact Your Access to Cancer Treatment, Management of Treat…

1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer 1:00:48

6M ago1:00:48

1:00:48

Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets.Par Neil Love, MD

1
What’s New in Precision Medicine 1:00:04

6M ago1:00:04

1:00:04

- Understanding Precision Medicine: Overview & Value of Precision Medicine- How Precision Medicine is Different from Targeted Treatments?- Precision Medicine Role’s in Informing Treatment Decisions: Predicting Response to Treatment- The Role of Precision Medicine in Deciding the Treatment for Lung Cancer, Leukemia & Colon Cancer- Talking with Your …

1
Ep 78. Research in Canada: Dr. Alain Tremblay GOMRG Winner 22:51

6M ago22:51

22:51

In today's episode, Dr. Paul Wheatley-Price sits down with Dr. Alain Tremblay, Professor of Medicine and Respirologist at the University of Calgary and Medical Lead of the Alberta Lung Cancer Screening program. Dr. Tremblay is the winner of the 2023 Geoffrey Ogram Memorial Research Grant for his project on implementing artificial intelligence (AI) …

1
Ep 77. Spotlight on Lung Cancer in Alberta 20:56

7M ago20:56

20:56

In this episode, Dr. Paul Wheatley-Price sits down with Nina Snyder, Chief Operations Officer at Alberta Lung. Nina introduces Alberta Lung as an organization and what they do to support Albertans living with lung disease, factors like radon and air quality that may lead to a lung cancer diagnosis, challenges like isolation, youth vaping and e-ciga…

1
Caring for Your Loved One with Cancer 1:00:43

7M ago1:00:43

1:00:43

- Definition of a Caregiver- What Research Tells Us About Caregivers’ Well Being- Caregiving for an Older Adult- Caregiving for a Younger Adult- Couples, Partners, Siblings, & Friends- Challenges for Caregivers of Cancer Survivors- Family, Partner, & Friend Communication- Care Coordination Challenges & Tips- Stresses on Family, Partners, Friends, &…

1
Diverse Populations Participating in Decisions about Your Care 57:57

7M ago57:57

57:57

- How Being a Member of Diverse Communities May Impact Your Access to Oncology Care, Treatment, Management of Treatment Side Effects & Pain Management- What to Expect from Your Relationship with Your Health Care Team: Is Your Health Care Team Providing You with Equitable, Excellent Care- What to Consider When Selecting a Cancer Care Team & Treatmen…

1
Ep 76. Research in Canada: Pfizer Grant Winner Dr. Rosalyn Juergens 19:34

7M ago19:34

19:34

In this episode, Dr. Paul Wheatley-Price sits down with Dr Rosalyn Juergens, Medical Oncologist at the Juravinski Cancer Center in Hamilton, ON and Chair of LCC's Medical Advisory Committee. Dr. Juergens is one of the winners of the Quality Improvement Grant aimed at elevating the care and outcomes of Canadians living with metastatic NSCLC. She cha…

1
Managing Eye and Vision Changes Related to Cancer Treatments 55:04

8M ago55:04

55:04

- Overview of Common Eye & Vision Changes Related to Cancer Treatments- Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors- Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters, & Flashing Lights- The Role of the Multidisciplinary Team- Tips to Manage Low …

1
Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates 32:24

8M ago32:24

32:24

Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors.Par Neil Love, MD

1
Ep 75. All About Oligoradiation and CURB 25:46

8M ago25:46

25:46

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Amir Safavi, final-year Radiation Oncology Resident at the University of Toronto, and Dr. Jillian Tsai, Staff Radiation Oncologist at Princess Margaret Cancer Centre. They preface the chat with radiation 101, describe what "oligo-" means in the context of oligoradiation, oligometastises & …

1
Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer 1:02:57

8M ago1:02:57

1:02:57

Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data with antibody-drug conjugates with established and investigational targets in patients with non-small cell lung cancer.Par Neil Love, MD

1
Understanding the Different Names for Biomarker Testing & Their Role in Selecting the Best Treatment for You 1:01:37

9M ago1:01:37

1:01:37

- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment- Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing- The Relationship Between Biomarker Testing & Precision Medicine- Types of Biomarker Tests for Cancer Treatment- Do I Need Biomarker Testing for…

1
Ep 74. The Palliative Care Early and Systematic (PaCES) Project 26:53

9M ago26:53

26:53

In this episode, Dr. Paul Wheatley-Price speaks to the team of The Palliative Care Early and Systematic (PaCES) Project out of the University of Calgary: Dr. Jessica Simon, Associate Professor and Head of the Division of Palliative Medicine; Lisa Shirt, RN, Clinical Nurse Specialist; and Tim Monds, stage 4 lung cancer survivor. What is the PaCES pr…

1
Chemotherapy: Novel Approaches to Prevent and Manage Gastrointestinal Treatment Side Effects 1:01:36

10M ago1:01:36

1:01:36

- Why Chemotherapy Causes Treatment Side Effects & Discomfort- Working with Your Healthcare Team to Better Understand & Cope with Potential Treatment Side Effects with a Plan to Manage or Prevent Them - Common Treatment Gastrointestinal (GI) Side Effects - You May Not Experience All of These - Loss of Appetite, Nausea, Vomiting, Mouth Sores, Stomat…

1
Understanding the Important Role that Biomarker Testing Plays in Informing the Treatment of Cancer 1:03:42

10M ago1:03:42

1:03:42

- Overview and Definition of Biomarkers- What Are Some Examples of Biomarker Testing- How Biomarker Testing Provides Useful Information for Cancer Treatment - Why the Molecular Portrait of Cancer Is So Important- The Role of the Pathologist- Benefits of Biomarker Testing & Precision Medicine- Predicting Response to Treatment- Clinical Trials: How R…

1
Young Adult Survivorship: Fertility, Sexuality and Intimacy 1:00:50

10M ago1:00:50

1:00:50

- Unique Needs of Young Adult Cancer Survivors- Identity, Relationships & Intimacy- Dating- Couples/Partners Dealing with Survivorship- Communicating about Sex- Sexuality & Intimacy- Sex Drive: Ability & Desire- Tips to Deal with Vaginal Dryness, Premature Menopause, Erectile Dysfunction, Premature Ejaculation & Sperm Banking- Low Desire: How to Ge…

1
Ep 73. Research in Canada: GOMRG Winner Dr. Enam Alsrayheen 17:40

10M ago17:40

17:40

In the second episode of our "Research in Canada" series, Dr. Paul Wheatley-Price meets with Dr. Enam Alsrayheen, Health Outcomes Scientist at Cape Breton Regional Hospital, who is a recipient of the 2023 Geoffrey Ogram Memorial Research Grant. Dr. Alsrayheen speaks about her research implementing a community lung clinic in the rural areas of Cape …

1
Non-Small Cell Lung Cancer: Biomarker Testing and Treatment 52:52

10M ago52:52

52:52

- Non-Small Cell Lung Cancer Overview, in the Context of COVID, Seasonal Flu & RSV- Definition of Genomics and Biomarker Testing- The Difference Between Genomics & Genetics- The Role of Biomarker Testing in the Treatment of Non-Small Cell Lung Cancer- Specific Examples of How Biomarker Testing May Inform Treatment Decisions- Precision Medicine & No…

1
Addressing the LGBTQI+ Health Disparities Gap 1:04:56

10M ago1:04:56

1:04:56

- Overview of Cancer & the LGBTQI+ Community, Including HIV & HPV- The LGBTQI+ Community’s Disproportionate Cancer Burden- Addressing the LGBTQI+ Health Disparities Gap, Including Mistrust of Health Care Providers- Barriers to Health Care Access, Including Discrimination- Health Care, Cancer Screening, Palliative and Supportive Care, Affordable Hou…

1
Ep 72. Research in Canada: LAA Winner Dr. Alison Wallace 15:04

11M ago15:04

15:04

In the first episode of our "Research in Canada" series, Dr. Paul Wheatley-Price speaks with Dr. Alison Wallace, Thoracic Surgeon and Associate Professor, Dalhousie University, recipient of a 2023 Lung Ambition Award. Dr. Wallace speaks about her research project focused on improving female patients’ quality of life when undergoing lung cancer surg…

Podcasts qui valent la peine d'être écoutés

Lung Cancer Podcasts

Podcasts qui valent la peine d'être écoutés

Guide de référence rapide